Vincent Aurentz – Biography
Last update: March 25, 2026Executive profile
Vincent was Chief Business Officer at Epirus Biopharmaceuticals, and Chairman of the Board at Dovetail Integrated Systems. Vincent Aurentz joined Inhibikase Therapeutics in 2025.
Vincent Aurentz is currentlyDirector at Inhibikase Therapeutics - View - Inhibikase Therapeutics org chart
Create your alert
to follow the career of Vincent Aurentz.
Education
Vincent Aurentz has a Bachelor of Science from Villanova University.
They have also studied at Villanova University :
Find more alumni from Villanova University
More about Vincent Aurentz
Selected links
Do you need to know more about Vincent Aurentz? More results.
Participate
Social media
- Vincent Aurentz on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Vincent Aurentz
The colleagues of Vincent Aurentz
Company Colleagues
- At Inhibikase Therapeutics, Vincent Aurentz has 17 colleagues including Mark Iwicki (CEO), Dennis Berman (Director)…
Industry Colleagues
- In the Biotechnology industry, Vincent Aurentz has 35,755 colleagues in 2,406 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Vincent Aurentz.
Get in Touch
Here are a few tips for establishing great contacts.
